News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
Study sheds light on why some breast cancers have limited response to immunotherapy
Jonathan Serody, MD, Benjamin Vincent, MD, and a team of UNC Lineberger investigators published findings in the Journal of Clinical Investigation that may explain why drugs designed to unleash the immune system against cancer were ineffective in treating a type of triple negative breast cancer. They determined “claudin-low” tumors were releasing a chemical signal to attract regulatory T-cells, which prevented the immune system from rejecting the cancer.
51 UNC Lineberger physicians recognized as 'Best Doctors'
Best Doctors in America® List is the product of a national survey of physicians, who are asked which physicians they would see if they needed treatment for specific medical issues.
Gillings names Ribisl chair of health behavior department
UNC Gillings School of Global Public Health has appointed UNC Lineberger's Kurt Ribisl, PhD, as chair of its health behavior department.
Researchers find genetic precursors of leukemia in cancer patients
A study led by UNC Lineberger's Catherine Coombs, MD, revealed new risk factors for “clonal hematopoiesis,” a medical phenomenon in which genetic mutations are found in the blood cells of patients who do not have an existing blood cancer.
Researchers look to improve detection of skin cancer lacking pigment melanin
UNC Lineberger researchers led by Nancy Thomas, MD, PhD, have identified key features linked to amelanotic melanoma, a form of skin cancer that lacks the brown or black color that stems from the pigment melanin.